These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22998395)

  • 21. A framework to link international clinical research to the promotion of justice in global health.
    Pratt B; Loff B
    Bioethics; 2014 Oct; 28(8):387-96. PubMed ID: 23278523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 'She's my sister-in-law, my visitor, my friend' -- challenges of staff identity in home follow-up in an HIV trial in Western Kenya.
    Madiega PA; Jones G; Prince RJ; Geissler PW
    Dev World Bioeth; 2013 Apr; 13(1):21-9. PubMed ID: 23521821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Access to treatment in HIV prevention trials: perspectives from a South African community.
    Barsdorf N; Maman S; Kass N; Slack C
    Dev World Bioeth; 2010 Aug; 10(2):78-87. PubMed ID: 19793135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV cure research in South Africa: a preliminary exploration of stakeholder perspectives.
    Moodley K; Staunton C; de Roubaix M; Cotton M
    AIDS Care; 2016; 28(4):524-7. PubMed ID: 26565595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Creating effective partnerships for HIV prevention trials: report of a UNAIDS Consultation, Geneva 20-21 June 2005.
    UNAIDS
    AIDS; 2006 Apr; 20(6):W1-11. PubMed ID: 16549961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stakeholder engagement to inform HIV clinical trials: a systematic review of the evidence.
    Day S; Blumberg M; Vu T; Zhao Y; Rennie S; Tucker JD
    J Int AIDS Soc; 2018 Oct; 21 Suppl 7(Suppl Suppl 7):e25174. PubMed ID: 30334358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Standardized metrics can reveal region-specific opportunities in community engagement to aid recruitment in HIV prevention trials.
    Broder GB; Lucas JP; Davis J; Wallace SE; Luthuli N; Baepanye K; White RR; Bolton M; Blanchette C; Andrasik MP
    PLoS One; 2020; 15(9):e0239276. PubMed ID: 32941520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The next 5 years of global HIV/AIDS policy: critical gaps and strategies for effective responses.
    Szekeres G
    AIDS; 2008 Aug; 22 Suppl 2():S9-17. PubMed ID: 18641475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Community perspectives on care options for HIV prevention trial participants.
    MacQueen KM; Namey E; Chilongozi DA; Mtweve SP; Mlingo M; Morar N; Reid C; Ristow A; Sahay S;
    AIDS Care; 2007 Apr; 19(4):554-60. PubMed ID: 17453597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 'over-researched community': An ethics analysis of stakeholder views at two South African HIV prevention research sites.
    Koen J; Wassenaar D; Mamotte N
    Soc Sci Med; 2017 Dec; 194():1-9. PubMed ID: 29035778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV Vaccine Trial participation in South Africa - an ethical assessment.
    Moodley K
    J Med Philos; 2002 Apr; 27(2):197-215. PubMed ID: 11961697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethical issues in HIV/AIDS research.
    Muthuswamy V
    Indian J Med Res; 2005 Apr; 121(4):601-10. PubMed ID: 15817966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rules of engagement: perspectives on stakeholder engagement for genomic biobanking research in South Africa.
    Staunton C; Tindana P; Hendricks M; Moodley K
    BMC Med Ethics; 2018 Feb; 19(1):13. PubMed ID: 29482536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Content analysis of local newspaper coverage of the microbicide trials in South Africa.
    Cooper S; Anafi P; Sun C; Naidoo N; Reddy P; Buchanan D
    Int Q Community Health Educ; 2008-2009; 29(2):105-21. PubMed ID: 19546087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ethical considerations in HIV prevention and vaccine research in resource-limited settings.
    Garner SA; Anude CJ; Adams E; Dawson L
    J Acquir Immune Defic Syndr; 2014 Sep; 67(1):77-83. PubMed ID: 25117930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. (Un)risky business: adolescents and HIV prevention trials.
    Philpott S
    Am J Bioeth; 2011 Jun; 11(6):17-9. PubMed ID: 21678207
    [No Abstract]   [Full Text] [Related]  

  • 37. "Why Don't You Go Into Suburbs? Why Are You Targeting Us?": Trust and Mistrust in HIV Vaccine Trials in South Africa.
    Thabethe S; Slack C; Lindegger G; Wilkinson A; Wassenaar D; Kerr P; Bekker LG; Mngadi K; Newman PA
    J Empir Res Hum Res Ethics; 2018 Dec; 13(5):525-536. PubMed ID: 30417754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cultural feasibility studies in preparation for clinical trials to reduce maternal-infant HIV transmission in Haiti.
    Coreil J; Losikoff P; Pincu R; Mayard G; Ruff AJ; Hausler HP; Desormeau J; Davis H; Boulos R; Halsey NA
    AIDS Educ Prev; 1998 Feb; 10(1):46-62. PubMed ID: 9505098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving ethical and participatory practice for marginalized populations in biomedical HIV prevention trials: lessons from Thailand.
    Allman D; Ditmore MH; Kaplan K
    PLoS One; 2014; 9(6):e100058. PubMed ID: 24949864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Community members' engagement with and involvement in genomic research: lessons to learn from the field.
    Folayan MO; Oyedeji KS; Fatusi OA
    Dev World Bioeth; 2015 Apr; 15(1):1-7. PubMed ID: 23594220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.